We reported an eight times increased frequency of insulin-positive cells co-expressing glucagon and a five times increased frequency of NKX6.1-positive, insulin-negative cells co-expressing glucagon in donors with type 2 diabetes compared to the control group (21). This evidence concerns the gene INS and type 2 diabetes mellitus.